BiotechTube
Home/Liquidia Corporation/Stephen Bloch, M.D.
SB

Stephen Bloch, M.D.

Chairman of the Board

Liquidia Corporation

Therapeutic Areas

Pulmonary Arterial HypertensionPulmonary Hypertension

Liquidia Corporation Pipeline

DrugIndicationPhase
YUTREPIA™ (treprostinil) inhalation powderPulmonary Arterial Hypertension (PAH)Approved
LIQ861 (treprostinil) inhalation powderPulmonary Arterial Hypertension (PAH)Phase 3
L606 (liposomal treprostinil) injectionPulmonary Arterial Hypertension (PAH)Preclinical

Leadership Team at Liquidia Corporation

RA
Roger A. Jeffs, Ph.D.
Chief Executive Officer & President
MK
Michael Kaseta
Chief Financial Officer & Treasurer
TS
Tushar Shah, M.D.
Chief Medical Officer
SB
Steven B. Simonson, M.D.
Senior Vice President, Clinical Development
JA
Jason Adair
Chief Operating Officer
DL
David L. Johnson
General Counsel & Corporate Secretary
View full Liquidia Corporation profile